HOME > BUSINESS > Article

Text Size

small

medium

large


Shionogi Aims to Start Supplying COVID-19 Remedy in FY 2021

Shionogi Aims to Start Supplying COVID-19 Remedy in FY 2021

   Osaka, May 11 (Jiji Press)--Japanese drugmaker Shionogi & Co. <4507> has said it aims to start supplying a COVID-19 remedy within fiscal 2021 at the earliest after starting a clinical trial by the end of September.
   Shionogi assumes that the government will fast-track its screening procedures for the drug. The company also hopes to begin supplying a coronavirus vaccine by December.

To read a full story, please click here to find out how to subscribe.

BUSINESS

Aomori Tourism Information

HEADLINES

POLITICS
Lockdown Easing in England to Be Delayed by One Month Due to Variant Risk
ECONOMY
Tokyo Stocks (Morning Close): Nikkei Average 29,375.94 (+214.14)
SPORTS
Men's Soccer: Slovakia, Czech Republic Record Wins in Euro 1st Round Matches
OTHER
COVID-19 Infection Cases in Africa Exceed 5 M., AFP Tally Shows

AFP-JIJI PRESS NEWS JOURNAL


Photos